Interestingly, many of these USP4 loss-of-function mutations, including L301R, S315C and R559W, are found mainly located in the catalytic domain of USP4, suggesting that the DUB activity is critical for maintaining BRCA1 stability and hence its tumor suppression function. The gene discussed is BRCA1; the disease is neoplasm.